RBC Capital Raises Price Target on Amgen (NASDAQ:AMGN) to $253 From $250By legume / August 4, 2023 / Amgen, Royal Bank of Canada RBC Capital Raises Price Target on Amgen (NASDAQ:AMGN) to $253 From $250, Maintains Sector Perform Rating.